These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15166488)

  • 21. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of airway hyperresponsiveness with reduced quality of life in patients with moderate to severe asthma.
    Porsbjerg C; Rasmussen L; Nolte H; Backer V
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):44-50. PubMed ID: 17225719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
    Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
    Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma.
    Cisneros C; García-Río F; Romera D; Villasante C; Girón R; Ancochea J
    Thorax; 2010 Sep; 65(9):795-800. PubMed ID: 20805173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
    Ferrari M; Benini L; Brotto E; Locatelli F; De Iorio F; Bonella F; Tacchella N; Corradini G; Lo Cascio V; Vantini I
    Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methacholine and adenosine 5'-monophosphate (AMP) responsiveness, and the presence and degree of atopy in children with asthma.
    Suh DI; Lee JK; Kim CK; Koh YY
    Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 2):e101-6. PubMed ID: 21342276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irritable bowel syndrome in young and elderly patients with stable asthma.
    Ekici A; Guliter S; Ekici M; Kalpaklioglu F; Kara T; Keles H; Tunckol M; Akin A; Kocyigit P
    Dig Liver Dis; 2005 Oct; 37(10):773-8. PubMed ID: 16023904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methacholine and adenosine inhalation challenge in patients with suspected asthma.
    Pedrosa M; Barranco P; Caminoa M; Botello MD; Quirce S
    J Asthma; 2009 Oct; 46(8):773-6. PubMed ID: 19863279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The characteristics of different diagnostic tests in adult mild asthmatic patients: comparison with patients with asthma-like symptoms by gastro-oesophageal reflux.
    Di Lorenzo G; Mansueto P; Esposito-Pellitteri M; Ditta V; Castello F; Lo Bianco C; Leto-Barone MS; Di Fede G; Traverso M; Rotolo G; Vigneri S; Rini G
    Respir Med; 2007 Jul; 101(7):1455-61. PubMed ID: 17360170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity.
    Ceyhan BB; Celikel T
    Int J Clin Pharmacol Ther; 1997 May; 35(5):208-13. PubMed ID: 9174876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial hyperresponsiveness and quality of life in asthmatics.
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; Ballone E; Menna V; Guagnano MT
    Respiration; 2003; 70(5):496-9. PubMed ID: 14665775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma.
    Roussos A; Koursarakos P; Patsopoulos D; Gerogianni I; Philippou N
    Respir Med; 2003 Jan; 97(1):75-9. PubMed ID: 12556015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of allergy in irritable bowel syndrome].
    Shiotani A
    Nihon Rinsho; 2006 Aug; 64(8):1532-5. PubMed ID: 16898627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of psychiatric disorders and irritable bowel syndrome in asthma patients.
    Yilmaz A; Cumurcu BE; Tasliyurt T; Sahan AG; Ustun Y; Etikan I
    Clinics (Sao Paulo); 2011; 66(4):591-7. PubMed ID: 21655752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of IBS in a cohort of people with asthma.
    Cole JA; Rothman KJ; Cabral HJ; Zhang Y; Farraye FA
    Dig Dis Sci; 2007 Feb; 52(2):329-35. PubMed ID: 17211701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable Bowel Syndrome and Bronchial Asthma: Are They Associated in Indian Population?
    Siddiqui S; Misra SP; Dwivedi M; Pant S
    J Clin Diagn Res; 2017 Feb; 11(2):OC21-OC23. PubMed ID: 28384910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Symptom Characteristics of Irritable Bowel Syndrome Among Bronchial Asthma Patients in Pakistan.
    Bachani P; Kumar L; Kumar N; Memon MK; Memon S; Irfan S; Alam O; Kumar B
    Cureus; 2020 Dec; 12(12):e12231. PubMed ID: 33500855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between irritable bowel syndrome and asthma: a meta-analysis and systematic review.
    Deshmukh F; Vasudevan A; Mengalie E
    Ann Gastroenterol; 2019; 32(6):570-577. PubMed ID: 31700233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.